Breaking News Instant updates and real-time market news.

ELOX

Eloxx Pharmaceuticals

$13.32

-0.08 (-0.60%)

, VRTX

Vertex

$177.51

2.49 (1.42%)

20:28
08/07/18
08/07
20:28
08/07/18
20:28

Eloxx Pharma's ELX-02 can address significant unmet need, says Piper Jaffray

Piper Jaffray analyst Edward Tenthoff kept his Overweight rating and $20 price target on Eloxx Pharmaceuticals (ELOX) after its Q2 earnings, saying the company's cash position of $63.4M is expected to keep it funded into 2020. The analyst notes that having cleared its pre-clinical trial application in Belgium, the company is preparing to initiate a Phase 2 study of ELX-02 in cystic fibrosis with G542X mutation in Q4, anticipating a readout in 2019. Tenthoff notes that Eloxx Pharma has an opportunity for the program given that up to 15% of CF patients do not respond to the current therapies offered by Vertex (VRTX).

ELOX

Eloxx Pharmaceuticals

$13.32

-0.08 (-0.60%)

VRTX

Vertex

$177.51

2.49 (1.42%)

  • 07

    Aug

  • 30

    Aug

  • 31

    Aug

ELOX Eloxx Pharmaceuticals
$13.32

-0.08 (-0.60%)

07/03/18
07/03/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Veru Inc. (VERU) initiated with a Buy at Maxim. 2. ViewRay (VRAY) initiated with a Buy at Jefferies. 3. MeiraGTx (MGTX) initiated with an Overweight at Barclays. 4. Zafgen (ZFGN) initiated with an Overweight at Piper Jaffray. 5. Eloxx Pharmaceuticals (ELOX) initiated with a Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/03/18
SBSH
07/03/18
INITIATION
Target $31
SBSH
Buy
Eloxx Pharmaceuticals initiated with a Buy at Citi
Citi analyst Joel Beatty started Eloxx Pharmaceuticals with a Buy rating and $31 price target.
06/29/18
06/29/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Construction Partners (ROAD) initiated with an Outperform at Imperial Capital. 2. Inovio (INO) assumed with an Overweight at Piper Jaffray. 3. GATX (GATX) initiated with a Buy at Mizuho. 4. Schneider National (SNDR) initiated with a Hold at Stifel. 5. Eloxx Pharmaceuticals (ELOX) initiated with a Buy at Canaccord. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/29/18
ADAM
06/29/18
INITIATION
Target $24
ADAM
Buy
Eloxx Pharmaceuticals initiated with a Buy at Canaccord
Canaccord analyst Arlinda Lee initiated Eloxx Pharmaceuticals with a Buy rating citing the read-through of its lead therapeutic candidate. She said although the company only has one lead candidate in the clinic, its proprietary platform could address the estimated 10-11% of human genetic disease caused by nonsense mutations. Lee has a $24 price target on Eloxx Pharmaceuticals shares.
VRTX Vertex
$177.51

2.49 (1.42%)

08/07/18
STFL
08/07/18
INITIATION
Target $200
STFL
Buy
Vertex transferred with a Buy at Stifel
Stifel transferred coverage of Vertex to analyst Paul Matteis, who set a Buy rating and $200 price target on the shares. Matteis thinks Vertex continues to build strong barriers to entry that in Cystic Fibrosis and believes that the company's non-CF pipeline largely represents upside to the stock.
07/27/18
PIPR
07/27/18
NO CHANGE
Target $230
PIPR
Overweight
Piper says Vertex faces 'onerous task' getting reimbursement for Symkevi in EU
After the EMA announced earlier that the CHMP adopted a positive opinion on Symkevi, Piper Jaffray analyst Edward Tenthoff said he expects EMA approval within the next few months, after which Vertex will face the "onerous task" of gaining European reimbursement. The analyst, who anticipates KALYDECO and ORKAMBI label expansions with PDUFA dates in August to continue to drive CF sales growth this year, keeps his Overweight rating and $230 price target on Vertex shares.
07/26/18
BMOC
07/26/18
NO CHANGE
Target $204
BMOC
Outperform
Vertex price target raised to $204 from $191 at BMO Capital
BMO Capital analyst Do Kim raised his price target on Vertex to $204 and kept his Outperform rating after "stellar" Q2 results that "easily" beat consensus due to the strong Symdeko sales. The analyst notes that Symdeko appears to be "capturing Orkambi switchers as well as naive patients and Orkambi dropouts", adding that its updated revenue guidance is likely to prove conservative on Symdeko's expansion potential.
07/26/18
OPCO
07/26/18
NO CHANGE
Target $200
OPCO
Outperform
Vertex price target raised to $200 from $180 at Oppenheimer
Oppenheimer analyst Hartaj Singh raised his price target for Vertex to $200 from $180 on "robust" Q2 results and accelerating pipeline. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

15:40
06/19/19
06/19
15:40
06/19/19
15:40
General news
Chair Powell's press conference has ended. The main take-away is the dovish stance »

Chair Powell's press…

DISH

Dish

$38.99

-0.09 (-0.23%)

, VZ

Verizon

$57.71

0.345 (0.60%)

15:38
06/19/19
06/19
15:38
06/19/19
15:38
Recommendations
Dish, Verizon, Sprint, T-Mobile analyst commentary  »

Citi sees 'several…

DISH

Dish

$38.99

-0.09 (-0.23%)

VZ

Verizon

$57.71

0.345 (0.60%)

S

Sprint

$7.47

0.25 (3.46%)

TMUS

T-Mobile

$78.38

1.89 (2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

AOS

A.O. Smith

$45.35

0.11 (0.24%)

15:37
06/19/19
06/19
15:37
06/19/19
15:37
Conference/Events
A.O. Smith management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 13

    Nov

CHS

Chico's

$3.19

0.09 (2.90%)

15:31
06/19/19
06/19
15:31
06/19/19
15:31
Hot Stocks
Chico's says will review $3 per share revised proposal from Sycamore Partners »

Chico's FAS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$16.20

0.08 (0.50%)

15:29
06/19/19
06/19
15:29
06/19/19
15:29
Conference/Events
Pure Storage management to meet with KeyBanc »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

  • 09

    Jul

MGA

Magna

$47.61

0.59 (1.25%)

15:29
06/19/19
06/19
15:29
06/19/19
15:29
Upgrade
Magna rating change  »

Magna upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSTO

Vista Outdoor

$8.12

0.025 (0.31%)

15:28
06/19/19
06/19
15:28
06/19/19
15:28
Conference/Events
Vista Outdoor management to meet with KeyBanc »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

CYTX

Cytori Therapeutics

$0.25

-0.0129 (-4.83%)

15:25
06/19/19
06/19
15:25
06/19/19
15:25
Conference/Events
Cytori Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 27

    Jun

15:20
06/19/19
06/19
15:20
06/19/19
15:20
General news
More Powell: there was talk about raising the inflation goal to 4% »

More Powell: there was…

SCS

Steelcase

$17.74

0.18 (1.03%)

15:19
06/19/19
06/19
15:19
06/19/19
15:19
Options
Steelcase options imply 11.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 24

    Jun

  • 26

    Jun

  • 10

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
06/19/19
06/19
15:17
06/19/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
06/19/19
06/19
15:16
06/19/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.86

0.53 (0.18%)

, SPX

S&P 500

$0.00

(0.00%)

15:14
06/19/19
06/19
15:14
06/19/19
15:14
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell says FOMC…

SPY

SPDR S&P 500 ETF Trust

$292.86

0.53 (0.18%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.81

0.48 (0.16%)

, SPX

S&P 500

$0.00

(0.00%)

15:13
06/19/19
06/19
15:13
06/19/19
15:13
General news
Powell says labor market 'in a good place' »

Fed Chair Powell said…

SPY

SPDR S&P 500 ETF Trust

$292.81

0.48 (0.16%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:10
06/19/19
06/19
15:10
06/19/19
15:10
General news
Powell: there was not much support for cutting rates now »

Powell: there was not…

FB

Facebook

$185.40

-3.06 (-1.62%)

, SPY

SPDR S&P 500 ETF Trust

$292.52

0.19 (0.06%)

15:04
06/19/19
06/19
15:04
06/19/19
15:04
General news
Powell says 'a long way' from digital currencies replacing traditional currency »

Facebook (FB) has…

FB

Facebook

$185.40

-3.06 (-1.62%)

SPY

SPDR S&P 500 ETF Trust

$292.52

0.19 (0.06%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 10

    Jul

AOBC

American Outdoor Brands

$9.05

0.01 (0.11%)

15:04
06/19/19
06/19
15:04
06/19/19
15:04
Options
American Outdoor Brands options imply 17.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

SPY

SPDR S&P 500 ETF Trust

$292.70

0.37 (0.13%)

, SPX

S&P 500

$0.00

(0.00%)

14:59
06/19/19
06/19
14:59
06/19/19
14:59
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell says 'we have…

SPY

SPDR S&P 500 ETF Trust

$292.70

0.37 (0.13%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$197.66

-0.86 (-0.43%)

, GS

Goldman Sachs

$195.44

0.455 (0.23%)

14:58
06/19/19
06/19
14:58
06/19/19
14:58
Periodicals
Apple expanding credit card test to thousands of retail workers, Bloomberg says »

Apple (AAPL) is ramping…

AAPL

Apple

$197.66

-0.86 (-0.43%)

GS

Goldman Sachs

$195.44

0.455 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 09

    Jul

  • 16

    Jul

RRGB

Red Robin

$31.03

-0.96 (-3.00%)

14:55
06/19/19
06/19
14:55
06/19/19
14:55
Hot Stocks
Red Robin says will review Vintage Capital request for special meeting »

In a filing, Red Robin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
06/19/19
06/19
14:55
06/19/19
14:55
General news
Powell: "i'm sure things will change before the next meeting," »

Powell: "i'm…

SPY

SPDR S&P 500 ETF Trust

$292.78

0.45 (0.15%)

, SPX

S&P 500

$0.00

(0.00%)

14:54
06/19/19
06/19
14:54
06/19/19
14:54
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell says 'not…

SPY

SPDR S&P 500 ETF Trust

$292.78

0.45 (0.15%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$250.98

5.33 (2.17%)

, DVA

DaVita

$51.30

1.54 (3.09%)

14:52
06/19/19
06/19
14:52
06/19/19
14:52
Periodicals
FTC approves UnitedHealth acquisition of Davita Medical, Forbes says »

The Federal Trade…

UNH

UnitedHealth

$250.98

5.33 (2.17%)

DVA

DaVita

$51.30

1.54 (3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

RRGB

Red Robin

$31.09

-0.9 (-2.81%)

14:52
06/19/19
06/19
14:52
06/19/19
14:52
Hot Stocks
Red Robin shareholder calls for board shakeup »

Vintage Capital, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$293.09

0.76 (0.26%)

, SPX

S&P 500

$0.00

(0.00%)

14:51
06/19/19
06/19
14:51
06/19/19
14:51
General news
Powell says no talks yet on whether next cut would be 25 or 50 basis points »

Fed chair Powell said the…

SPY

SPDR S&P 500 ETF Trust

$293.09

0.76 (0.26%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.